Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,796 total articles
Caring Brands Inc. (NASDAQ: CABR) announced the initial $4.6 million closing of an ongoing $9 million private placement. The proceeds will be used to launch new salesforce and marketing campaigns aiming to accelerate revenue growth. Additional closings are anticipated pending fund clearance. The company continues to develop and commercialize innova…
Ruanyun Edai Technology Inc. (NASDAQ: RYET) announced it has secured a RMB5.99 million (approx. US$0.88 million) contract to deploy its YeeZo AI workflow and orchestration platform across 10 AI-generated content vocational training laboratories in China. This marks a significant commercial milestone as YeeZo moves from platform launch to institutio…
Aurora Mobile Limited participated in the China-Thailand Digital Economy Cooperation event at Big Data Expo 2026, sharing insights on digital expansion and AI adoption in Southeast Asia. The company highlighted its extensive operations in ASEAN, strategic partnerships, and commitment to fostering localized digital solutions while addressing regulat…
INNOVATE Corp. has closed the sale wherein CONX Corp. acquired a 75% controlling interest in HC2 Broadcasting Holdings, the company's broadcasting segment. INNOVATE maintains a 25% stake and retains options for further ownership changes over the next 18 months to two years. The transaction strengthens INNOVATE's balance sheet and positions HC2 for …
Roper Technologies, a constituent of the Nasdaq 100, S&P 500, and Fortune 500, announced its participation in the Goldman Sachs Communacopia + Technology Conference. The company emphasizes its strong track record in cash flow growth and shareholder value through its businesses focusing on vertical software and technology-enabled products across nic…
Veru Inc. announced participation in the 2026 Cantor Global Healthcare Conference where CEO Mitchell Steiner will discuss ongoing clinical developments. The company focuses on late-stage biopharmaceutical programs, notably the Phase 2b PLATEAU trial evaluating enobosarm in combination with GLP-1 receptor agonists for improved weight reduction and m…
Artiva Biotherapeutics, a clinical-stage biotechnology company focused on cell therapies for autoimmune diseases, announced its management will participate in the 2026 Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company is initiating a Phase 3 registrational trial for its lead product, A…
Equillium, Inc., a biotech firm focused on therapies for autoimmune and inflammatory disorders, announced its management team's participation in the Cantor Global Healthcare Conference 2026 and the H.C. Wainwright 28th Annual Global Investment Conference. The company plans to conduct presentations, fireside chats, and one-on-one meetings with inves…
Orion Energy Systems, Inc., a provider of energy-efficient LED lighting, EV charging stations, and maintenance services, announced its participation in the 28th Annual H.C. Wainwright Global Investment Conference taking place September 14-16, 2026. CEO Sally Washlow will deliver a company presentation and hold one-on-one investor meetings.
SciSparc Ltd., via its subsidiary NeuroThera Labs, is pursuing FDA Orphan Drug Designation for SCI-110, a cannabinoid-based treatment for adult Tourette Syndrome. To support regulatory and market access efforts, NeuroThera has engaged RK Strategies, a U.S. public affairs firm. SCI-110 has shown promising early clinical results and is now in Phase I…
Verisk and the American Property Casualty Insurance Association report a $31.7 billion net underwriting gain for the U.S. property/casualty insurance industry in the first half of 2026, driven by improved profitability and higher investment income despite ongoing challenges with catastrophe exposure and casualty lines. The industry's policyholders'…
GlobalFoundries and RAAAM Memory Technologies have successfully taped out a Gain-Cell RAM (GCRAM) test chip on GlobalFoundries' FDX FD-SOI platform. This collaboration aims to deliver higher-density, lower-power on-chip memory solutions optimized for edge AI, automotive, and IoT markets. The new memory technology offers significant area and power s…
Maris-Tech Ltd., a Nasdaq-listed Israeli company specializing in video and AI-based edge computing technology for defense and aerospace sectors, announced a 194% increase in revenue to approximately $2.1 million for the first half of 2026. Despite this strong revenue growth, the company reported a net loss of $2.8 million compared to net income of …
Fluent, Inc., a commerce media solutions provider, announced its CEO and CFO will participate in the 19th Annual Barrington Research Virtual Fall Investment Conference, engaging in one-on-one meetings to discuss company performance and outlook.
ProQR Therapeutics, a clinical-stage company specializing in RNA therapies, announced management's participation in Wells Fargo and Cantor Global Healthcare investor conferences in September 2026. The company will discuss its pioneering Axiomer™ RNA editing technology, which aims to develop new medicines by correcting RNA mutations. Webcasts will b…
Insight Molecular Diagnostics Inc. announced its participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth Conference scheduled for September 10, 2026, where its CEO and CFO will engage in one-on-one investor meetings in New York City.
CG Oncology, Inc., a late-stage clinical biopharmaceutical company focused on bladder cancer immunotherapies, announced the participation of its CEO, Arthur Kuan, in the Cantor Fitzgerald and Morgan Stanley Global Healthcare Conferences in September 2026. The company will webcast the presentations live and make replays available to investors.
vTv Therapeutics Inc., a late-stage biopharmaceutical company developing an oral investigational therapy for type 1 diabetes, will participate in two major investor conferences in September. The company’s leading drug candidate, cadisegliatin, a novel oral glucokinase activator with Breakthrough Therapy designation, is currently being evaluated in …
Milestone Pharmaceuticals Inc., a biopharmaceutical company specializing in cardiovascular medicines, announced that its management will present at several forthcoming investor conferences including Wells Fargo, Cantor Global Healthcare, and H.C. Wainwright. The company is known for its lead FDA-approved product CARDAMYST, a nasal spray treating pa…
The U.S. Court of Appeals for the Second Circuit officially vacated a preliminary injunction that had restricted Genius Group Limited from issuing shares, raising capital, and purchasing Bitcoin. This marks the end of an 18-month legal battle with LZG International. The lifting of the injunction allows Genius Group to fully proceed with its board-a…
Aligos Therapeutics, a clinical-stage biotech company focused on liver and viral diseases, announced its management will present at the Cantor Global Healthcare Conference on September 9, 2026. The presentation will review the company's scientific approach and development of therapies, particularly for chronic hepatitis B. The company also highligh…
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company specializing in nitric oxide therapies, announced its management will participate in the 2026 Cantor Global Healthcare Conference. The company will hold a fireside chat and offer a webcast to discuss its latest developments, including its FDA-approved LungFit PH syste…
UroGen Pharma Ltd., a biotech company focused on urothelial and specialty cancers, announced it will participate in key healthcare investor conferences in September 2026, including Wells Fargo, Cantor Global, and H.C. Wainwright events. Presentations will be webcast and available for replay on the company's website.
Design Therapeutics, a clinical-stage biotech company developing GeneTAC® gene targeted chimera small molecule therapies for degenerative genetic diseases, announced management will participate in a fireside chat at the 2026 Cantor Fitzgerald Global Healthcare Conference. The webcast will highlight the company's pipeline, including programs for Fri…
DDC Enterprises Ltd. reported significant progress in the first half of 2026, showing a 29% revenue increase in its Asian food platform, positive adjusted EBITDA, and a large expansion of its Bitcoin treasury to 2,899 BTC. The company improved its working capital position substantially and launched a share repurchase program, while continuing to de…
